Key Metrics of Vicore Pharma Holding AB
Market cap$2.8BVCRE · $9.80
Competitors10identified
About Vicore Pharma Holding AB
Sectors
Company details
- Website
- vicorepharma.com
- Listed
- Nasdaq: VCRE
Operational Areas of Vicore Pharma Holding AB
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameVicore Pharma Holding AB
TickerVCRE
ExchangeNasdaq
CountrySweden
SEC CIK0002124403
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttps://vicorepharma.com
US market & SEC filings
VCRE · Nasdaq · SEC CIK 0002124403
Last price · 02 Nov 2026
$9.80
−3.92%
Market cap$2.8B
P/E—
Volume11,890
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOSweden
VCRE share price
Annual results (SEC EDGAR)
No annual results in SEC XBRL data for this company yet.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeGothenburg Municipality
GSTIN—
Email—
Websitehttps://vicorepharma.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Vicore Pharma Holding AB
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Similar companies
Z
Zai Lab LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
BeOne Medicines Ltd.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
J
Jazz Pharmaceuticals plcPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
K
Kamada Ltd.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
N
Nasus Pharma Ltd.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
A
Achieve Life Sciences Inc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
S
SciSparc Ltd.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
T
Teva Pharmaceutical Industries LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.